Clinical Trial: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of IBIO-600 in Overweight or Obese Adults

U.S., March 24 -- ClinicalTrials.gov registry received information related to the study (NCT07487376) titled 'A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of IBIO-600 in Overweight or Obese Adults' on March 12.

Brief Summary: The goal of this clinical trial is to learn which dose of study drug IBIO-600 has the right balance of safety, tolerability and impact on body composition in overweight and obese adult participants.

Study Start Date: April, 2026

Study Type: INTERVENTIONAL

Condition: Overweight , Obesity

Intervention: DRUG: IBIO-600

IBIO-600 Subcutaneous injection

DRUG: Placebo

Matching placebo; subcutaneous injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: iBi...